SGRY VS NVST Stock Comparison
Performance
SGRY10/100
10/100
SGRY returned 4.97% in the last 12 months. Based on SPY's performance of 13.09%, its performance is below average giving it a score of 10 of 100.
NVST10/100
10/100
NVST returned -38.34% in the last 12 months. Based on SPY's performance of -13.74%, its performance is below average giving it a score of 10 of 100.
Analyst Price Targets
SGRY61/100
61/100
9 analysts offer 12-month price targets for SGRY. Together, they have an average target of 64, the most optimistic target put SGRY at 64 within 12-months and the most pessimistic has SGRY at 64.
NVST
"Analyst Price Targets" not found for NVST
Technicals
SGRY64/100
64/100
SGRY receives a 64 of 100 based on 14 indicators. 8 are bullish, 4 are bearish.
NVST50/100
50/100
NVST receives a 50 of 100 based on 14 indicators. 6 are bullish, 6 are bearish.
Earnings
SGRY10/100
10/100
SGRY has missed earnings 11 times in the last 20 quarters.
NVST33/100
33/100
NVST has missed earnings 3 times in the last 20 quarters.
Profit
SGRY61/100
61/100
Out of the last 20 quarters, SGRY has had 14 profitable quarters and has increased their profits year over year on 7 of them.
NVST62/100
62/100
Out of the last 20 quarters, NVST has had 18 profitable quarters and has increased their profits year over year on 6 of them.
Volatility
SGRY47/100
47/100
SGRY has had a lower than average amount of volatility over the last 12 months giving it a score of 47 of 100.
NVST38/100
38/100
NVST has had a lower than average amount of volatility over the last 12 months giving it a score of 37 of 100.
All score calculations are broken down here to help you make more informed investing decisions
Surgery Partners, Inc. Common Stock Summary
Nasdaq / SGRY
Healthcare
Medical - Care Facilities
Surgery Partners, Inc., through its subsidiaries, owns and operates a network of surgical facilities and ancillary services in the United States. The company operates through two segments, Surgical Facility Services and Ancillary Services. Its surgical facilities comprise ambulatory surgery centers and surgical hospitals that offer non-emergency surgical procedures in various specialties, including gastroenterology, general surgery, ophthalmology, orthopedics, and pain management. The company's surgical hospitals also provide ancillary services, such as diagnostic imaging, pharmacy, laboratory, obstetrics, oncology, physical therapy, and wound care; and ancillary services, which consist of multi-specialty physician practices, urgent care facilities, and anesthesia services. As of December 31, 2021, it owned or operated a portfolio of 126 surgical facilities, including 108 ambulatory surgical centers and 18 surgical hospitals in 31 states. Surgery Partners, Inc. was founded in 2004 and is headquartered in Brentwood, Tennessee.
Envista Holdings Corporation Common stock, $0.01 par value per share Summary
New York Stock Exchange / NVST
Healthcare
Medical - Instruments & Supplies
Envista Holdings Corporation, together with its subsidiaries, engages in the development, sale, and marketing of dental products in the United States, China, and internationally. The company operates in two segments, Specialty Products & Technologies and Equipment & Consumables. The company's Specialty Products & Technologies segment provides dental implant systems, guided surgery systems, biomaterials, and prefabricated and custom-built prosthetics to oral surgeons, prosthodontists, and periodontists under the Nobel Biocare, Alpha-Bio Tec, Implant Direct, Nobel Procera, and Orascoptic brands; and brackets and wires, tubes and bands, archwires, clear aligners, digital orthodontic treatments, retainers, and other orthodontic laboratory products under the Damon, Insignia, AOA, and Spark brands. This segment also offers software packages, which include DTX Studio Implant for treatment planning of dental implants; TX Studio Lab for prosthetics treatment planning; and DTX Studio Clinic to store and access a various clinical patient images. The company's Equipment & Consumables segment provides dental equipment and supplies, including digital imaging systems, sensors, software, and other visualization/magnification systems; endodontic systems and related consumables; restorative materials, rotary burs, impression materials, bonding agents, and cements; and infection prevention products. This segment offers its products under the Dexis, Gendex, i-CAT, Kerr, Metrex, Total Care, Pentron, Optibond, Harmonize, Sonicfill, Sybron Endo, and CaviWipes to dental offices, clinics, and hospitals. Envista Holdings Corporation was incorporated in 2018 and is headquartered in Brea, California.
Power up your portfolio
Build a portfolio of your favorite stocks
Pluto makes it easy to build investing strategies and automate your portfolio
Compare Similar Companies
Compare SGRY to other companies in the same or a similar industry.